These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7919576)

  • 21. Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections.
    Wacha H; Warren B; Bassaris H; Nikolaidis P;
    Surg Infect (Larchmt); 2006 Aug; 7(4):341-54. PubMed ID: 16978077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin versus gentamicin/clindamycin for postpartum endometritis.
    Maccato ML; Faro S; Martens MG; Hammill HA
    J Reprod Med; 1991 Dec; 36(12):857-61. PubMed ID: 1816396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection.
    Licitra CM; Brooks RG; Sieger BE
    Antimicrob Agents Chemother; 1987 May; 31(5):805-7. PubMed ID: 3606079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient.
    Pea F; Cojutti P; Sbrojavacca R; Cadeo B; Cristini F; Bulfoni A; Furlanut M
    Ann Pharmacother; 2011 Jul; 45(7-8):e37. PubMed ID: 21750307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous ciprofloxacin.
    Med Lett Drugs Ther; 1991 Aug; 33(850):75-6. PubMed ID: 2072876
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential intravenous/oral therapy with ciprofloxacin in severe infection.
    Chrysanthopoulos CJ; Starakis JC; Skoutelis AT; Bassaris HP
    Am J Med; 1989 Nov; 87(5A):225S-227S. PubMed ID: 2589365
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections.
    Tice AD; Marsh PK; Craven PC
    Diagn Microbiol Infect Dis; 1990; 13(2):165-7. PubMed ID: 2196153
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonoperative management of diabetic foot infections.
    Wakefield MC; Kan VL; Arora S; Weiswasser J; Sidawy AN
    Semin Vasc Surg; 2003 Mar; 16(1):79-85. PubMed ID: 12644977
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral ciprofloxacin in refractory gram-negative bacillary infections.
    Bryant RE; Hartstein AI
    Int J Clin Pharmacol Res; 1987; 7(3):187-94. PubMed ID: 3596862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin as an alternative to i.v. therapy.
    Fazio A
    Am J Hosp Pharm; 1990 Dec; 47(12):2660. PubMed ID: 2278282
    [No Abstract]   [Full Text] [Related]  

  • 32. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
    Parish LC; Asper R
    Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of patients with purulent infection with intravenous infusions of silver chloride ammonia solutions].
    Abrosimov IP; Dzhambanov MM; Popovskií AS; Molchanov VI
    Khirurgiia (Mosk); 1997; (7):62-3. PubMed ID: 9379609
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of intravenous ciprofloxacin in difficult-to-treat infections.
    Giamarellou H; Galanakis N
    Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An assessment of ciprofloxacin per os in treatment of serious infections.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Beziau H
    Chemioterapia; 1987 Jun; 6(2 Suppl):391-4. PubMed ID: 3509456
    [No Abstract]   [Full Text] [Related]  

  • 36. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing.
    Hollenstein UM; Brunner M; Schmid R; Müller M
    Int J Obes Relat Metab Disord; 2001 Mar; 25(3):354-8. PubMed ID: 11319632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.
    Nix DE; Sands MF; Peloquin CA; Vari AJ; Cumbo TJ; Vance JW; Fracasso JE; Schentag JJ
    Am J Med; 1987 Apr; 82(4A):352-6. PubMed ID: 3555060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency.
    Pai MP; Mercier RC; Allen SE
    Ann Pharmacother; 2006 Mar; 40(3):553-8. PubMed ID: 16507618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The treatment of gastrointestinal infections with ciprofloxacin].
    Ippolito A; La Gioia G; Matarrese M; Resta F; Angelini P; Ruffo F
    Minerva Med; 1991 Apr; 82(4):181-7. PubMed ID: 2017314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of ciprofloxacin in gynaecological infections.
    Loendersloot E; Branolte JH
    J Chemother; 1989 Jul; 1(4 Suppl):888-9. PubMed ID: 16312688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.